Skip to main content

Table 1 Patient and disease characteristics

From: Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response

  # (%) [range]
Number of patients 32   
 Male 14 (40%)  
 Female 19 (60%)  
Median age on starting tamoxifen 41   [19–68]
Site of origin    
 Extremities (including girdle) 18 (56%)  
 Chest wall 5 (15%)  
 Pelvis 3 (10%)  
 Abdominal wall 3 (10%)  
 Paravertebral 1 (3%)  
 Head and neck 2 (6%)  
Sporadic disease 31 (97%)  
FAP-associated 1 (3%)  
Previous treatments 18 (56%)  
 Local treatment
  Surgery 10 (31%)  
  Surgery and RT 7 (21%)  
  RT alone 0   
 Systemic treatment 4 (12%)  
No previous treatment 14 (44%)